Stock Yards Bank & Trust’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Hold |
10,500
| – | – | ﹤0.01% | 381 |
|
|
2025
Q1 | $12.8K | Hold |
10,500
| – | – | ﹤0.01% | 379 |
|
|
2024
Q4 | $13.5K | Hold |
10,500
| – | – | ﹤0.01% | 365 |
|
|
2024
Q3 | $28.9K | Hold |
10,500
| – | – | ﹤0.01% | 373 |
|
|
2024
Q2 | $23.7K | Hold |
10,500
| – | – | ﹤0.01% | 376 |
|
|
2024
Q1 | $25.1K | Hold |
10,500
| – | – | ﹤0.01% | 391 |
|
|
2023
Q4 | $17.4K | Hold |
10,500
| – | – | ﹤0.01% | 377 |
|
|
2023
Q3 | $20.2K | Hold |
10,500
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $15.1K | Hold |
10,500
| – | – | ﹤0.01% | 393 |
|
|
2023
Q1 | $22K | Hold |
10,500
| – | – | ﹤0.01% | 404 |
|
|
2022
Q4 | $12K | Hold |
10,500
| – | – | ﹤0.01% | 411 |
|
|
2022
Q3 | $17K | Hold |
10,500
| – | – | ﹤0.01% | 405 |
|
|
2022
Q2 | $14K | Hold |
10,500
| – | – | ﹤0.01% | 414 |
|
|
2022
Q1 | $17K | Buy |
+10,500
| New | +$17K | ﹤0.01% | 269 |
|